MAP Mapfre, S.A.
Mapfre, S.A., together with its subsidiaries, engages in insurance, reinsurance, and financial activities in Spain. The company offers life; health; accident; property and casualty protection that include automobile insurance, homeowner and commercial risk, and family third-party liability insurance; savings and investment; retirement; burial; travel and leisure insurance; and agriculture and livestock insurance products. It also provides investment and pension funds; reinsurance services; insurance for businesses; and business multirisk insurance. The company serves its products to companies, small, medium, and large corporations, as well as to professionals, entrepreneurs, the self-employed, and small businesses. The company was formerly known as Corporacion Mapfre and changed its name to Mapfre, S.A. in December 2006. Mapfre, S.A. was founded in 1933 and is based in Majadahonda, Spain. Mapfre, S.A. operates as a subsidiary of Cartera Mapfre, S.L.…
Industry Peers
Insurance - DiversifiedKey Statistics
About Mapfre (BME: MAP)
›
Mapfre (BME: MAP) is listed on the Bolsa de Madrid, where its shares trade in EUR. It belongs to the Insurance - Diversified industry, part of the Financial Services sector, and reports about 30,846 employees.
The shares were at 4.114 EUR on 19 November 2026, up 4.1% over 52 weeks. Its 52-week range is 3.520 EUR to 4.616 EUR: the price is 10.9% below the high and 16.9% above the low.
At a market capitalisation of 12.63B EUR, it trades at 10.8 times trailing earnings and 9.7 times forward earnings. The median trailing P/E of its 20 largest Insurance - Diversified peers is 15.6, a discount of 31% for MAP. It pays a dividend yielding 4.34% (it pays out 47% of its earnings), against a median of 3.92% among the dividend payers in that peer group.
Mapfre reports return on equity of 12.0%, an operating margin of 11.7% and revenue up 43.1% year over year.
Its debt exceeds its cash by 841.60M EUR, a debt-to-equity ratio of 0.32. Its Piotroski F-score is 3 out of 9, a weak reading of its financial health. 10 analysts cover the stock, with an average rating of Hold; their mean price target of 4.325 EUR is 5.1% above the current price. The next earnings report is expected on 11 February 2027.